Je. Pawlowski et al., STIMULATION OF ACTIVIN-A EXPRESSION IN RAT AORTIC SMOOTH-MUSCLE CELLSBY THROMBIN AND ANGIOTENSIN-II CORRELATES WITH NEOINTIMAL FORMATION IN-VIVO, The Journal of clinical investigation, 100(3), 1997, pp. 639-648
Vasoactive GTP-binding protein-coupled receptor agonists (e.g., angiot
ensin II [ALI] and alpha-thrombin) stimulate the production of mitogen
ic factors from vascular smooth muscle cells, In experiments to identi
fy mitogens secreted from AII- or alpha-thrombin-stimulated rat aortic
smooth muscle (RASM) cells, neutralizing antibodies directed against
several growth factors (e.g., PDGF and basic fibroblast growth factor
[basic FGF]) failed to inhibit the mitogenic activity of conditioned m
edia samples derived from the cells, In this report, we found that pol
yclonal neutralizing antibodies directed against purified human placen
tal basic FGF reduced the mitogenic activity of AII-stimulated RASM ce
ll-conditioned media and in immunoblot experiments identified a 26-kD
protein (14 kD under reducing conditions) that was distinct from basic
FGF, After purification from RASM cell-conditioned medium, amino acid
sequence analysis identified the protein as activin A, a member of th
e TGF-beta superfamily, Increased activin A expression was observed af
ter treatment of the RASM cells with AII, alpha-thrombin, and the prot
ein kinase C agonist PMA. In contrast, PDGF-BB or serum caused only a
minor induction of this protein. Although activin A alone only weakly
stimulated RASM cell DNA synthesis, it demonstrated a potent comitogen
ic effect in combination with either EGF or heparin-binding EGF-like g
rowth factor in the RASM cells, increasing DNA synthesis by up to four
fold. Furthermore, in a rat carotid injury model, activin A mRNA was u
pregulated within 6 h after injury followed by increases in immunoreac
tive protein detected in the expanding neointima 7 and 14 d later. Tak
en together, these results indicate that activin A is a vascular smoot
h muscle cell-derived factor induced by vasoactive agonists that may,
either alone or in combination with other vascular derived growth fact
ors, have a role in neointimal formation after arterial injury.